Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Will The Vascular Dementia Market Valuation Change Between Now And 2029?

In recent times, the market size for vascular dementia has experienced a swift expansion. The market is projected to inflate from $2.92 billion in 2024 to a size of $3.27 billion by 2025, indicating a compound annual growth rate (CAGR) of 11.8%. The previous growth observed can be credited to numerous factors such as an increase in healthcare spending, heightened patient diagnoses of vascular dementia, a larger number of healthcare professionals, the expansion of public health initiatives, as well as the rising prevalence of diabetes.

The size of the vascular dementia market is poised to experience a significant upturn in the coming years. It is projected to swell to $5.07 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.6%. This anticipated growth in the forecasted period can be credited to the growing cognizance of vascular dementia, an increase in healthcare spending, the aging of the global population, a surge in cardiovascular diseases, and a rise in high blood pressure cases. Key trends predicted for the forecast period encompass tech innovations, tailoring of care plans to individual needs, the adoption of telemedicine, the advent of gene therapy, and the increased application of artificial intelligence.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20998&type=smp

What Growth-Enabling Forces Are Impacting The Vascular Dementia Market?

The growing incidence of cardiovascular disease is anticipated to boost the progression of the vascular dementia market in the future. Cardiovascular diseases encompass a series of maladies that impact the heart and blood vessels and include conditions such as coronary artery disease, heart failure, arrhythmias, and hypertension. Factors such as unhealthy lifestyles, poor nutrition, physical inactivity, heightened stress levels, aging demographics, and a proliferation in risk features like obesity, diabetes, and hypertension contribute to the growing incidence of these diseases. Cardiovascular diseases raise the risk of vascular dementia by disrupting blood circulation to the brain, resulting in cognitive deterioration and brain cell damage due to inadequate oxygen and nutrient delivery. In September 2024, for example, data released by the British Heart Foundation, a cardiovascular research charity based in the UK, demonstrated that around 7.6 million people in the UK are suffering from heart and circulatory diseases, including nearly 4 million men and 3.6 million women. These diseases are accountable for roughly 27% of all deaths in the UK, corresponding to over 170,000 deaths per year or approximately 480 daily deaths which equates to one death every three minutes. Consequently, the growing incidence of cardiovascular diseases propels the growth in the vascular dementia market.

What Are The Main Segment Classifications In The Vascular Dementia Market?

The vascular dementiamarket covered in this report is segmented –

1) By Product: Monoclonal Antibodies; Small Molecules; Peptides

2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

3) By End User: Hospitals And Clinics; Rehabilitation Centers; Specialty Clinics

Subsegments:

1) By Monoclonal Antibodies: Anti-Amyloid Monoclonal Antibodies; Anti-Tau Monoclonal Antibodies

2) By Small Molecules: Cholinesterase Inhibitors; Glutamate Modulators; Anti-Inflammatory Small Molecules

3) By Peptides: Amyloid-Beta Targeted Peptides; Neuroprotective Peptides; Tau-Targeting Peptides

Which Emerging Trends Are Reshaping The Vascular Dementia Market Landscape?

In a quest to maintain their market position, key players in the vascular dementia market are prioritizing the creation of innovative therapies such as multimodal treatments. These therapies involve the use of various strategies like medication, physical therapy, and psychological interventions to comprehensively address a condition. For example, in January 2023, Moleac, a biopharmaceutical firm based in Singapore, introduced CognivAiD – a treatment specifically designed for vascular dementia (VaD), an ailment with few effective treatments. CognivAiD incorporates potent extracts from ginkgo, ginseng, and saffron, known to significantly impede cognitive decline in VaD patients. The extraordinary multimodal action of CognivAiD targets key vascular dementia procedures including vascular protection, vasoregulation, and neuroinflammation. Backed by a plethora of clinical research and a robust safety profile, CognivAiD provides a promising therapeutic avenue for those battling VaD.

Which Firms Are Driving Innovation Within The Vascular Dementia Market?

Major companies operating in the vascular dementia market are Intermountain Healthcare Inc., CSPC Ouyi Pharmaceutical Co. Ltd., Duke Health, Massachusetts General Hospital, Emory Healthcare Inc., Apollo Hospitals Enterprise Limited, Amedisys Inc., Northwestern Memorial HealthCare, IBS Hospitals Pvt. Ltd., Resverlogix Corp., ProNeurogen Inc., Cyclerion Therapeutics Inc., Aribio Inc., Pinteon Therapeutics Inc., Dementech Neurosciences Ltd., Moleac Pte. Ltd., Isaac Health Inc., Cadabam’s Group of Hospitals, Alpha Cognition Inc., Citi Health

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/vascular-dementia-global-market-report

What Are The Emerging Regional Trends Driving The Vascular Dementia Market?

North America was the largest region in the vascular dementia market in 2024. The regions covered in the vascular dementia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=20998&type=smp

Browse Through More Reports Similar to the Global Vascular Dementia Market 2025, By The Business Research Company

Lewy Body Dementia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lewy-body-dementia-treatment-global-market-report

Anti Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report

Vascular Embolization Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model